Showing results (301-310 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|October 31, 2015
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage ResponseTakayo Fukuda, Tomoko Tsuruga, Takako Kuroda, et al.Current Cancer Drug Targets|September 29, 2015
Extracellular Vesicles as Novel Delivery Tools for Cancer TreatmentErdogan Pekcan Erkan, Okay SaydamCurrent Cancer Drug Targets|September 2, 2015
Nuclear Export as a Novel Therapeutic Target: The CRM1 ConnectionChuanwen Lu, Jose A Figueroa, Zhongwei Liu, et al.Current Cancer Drug Targets|October 29, 2014
Nontoxic-dose of deguelin induce NPMc+ AML cell differentiation by selectively targeting Mt NPM1/SIRT1 instead of HDAC1/3You Ping Wang, Sha Yi, Lu Wen, et al.Current Cancer Drug Targets|October 29, 2014
AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1Alexandra Schrader, Wagma Popal, Nils Lilienthal, et al.Current Cancer Drug Targets|October 29, 2014
Bioactive albumin-based carriers for tumour chemotherapyYasser Shahzad, Ikram Ullah Khan, Talib Hussain, et al.Current Cancer Drug Targets|October 29, 2014
TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell linesPan Ni, Wenxia Xu, Yajie Zhang, et al.Current Cancer Drug Targets|December 30, 2014
Novel synthetic pharmacophores inducing a stabilization of cellular microtubulesAnne Martinez, Emmanuelle Soleilhac, Caroline Barette, et al.Current Cancer Drug Targets|November 17, 2020
Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their SecretomeValentina Coccè, Arianna Bonomi, Loredana Cavicchini, et al.Current Cancer Drug Targets|November 23, 2020
Concomitant expression of inhibitory molecules for T cell activation predicts poor survival in patients with esophageal squamous cell carcinomaZhijun Chen, Kexin Cao, Jinghang Zhang, et al.Pageof 187